Genotype-phenotype correlation in Tunisian patients with Amyotrophic Lateral Sclerosis

[1]  D. McKim,et al.  Laryngospasm in amyotrophic lateral sclerosis , 2021, Muscle & nerve.

[2]  A. Ratti,et al.  Genetic and epigenetic disease modifiers in an Italian C9orf72 family expressing ALS, FTD or PD clinical phenotypes , 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[3]  A. Gitler,et al.  ALS Genetics: Gains, Losses, and Implications for Future Therapies , 2020, Neuron.

[4]  Jinsy A. Andrews,et al.  Amyotrophic lateral sclerosis: update on clinical management , 2020, Current opinion in neurology.

[5]  Denis C. Bauer,et al.  Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis , 2020, Journal of Medical Genetics.

[6]  G. Rouleau,et al.  Oligogenicity, C9orf72 expansion, and variant severity in ALS , 2020, neurogenetics.

[7]  M. Picot,et al.  Clinical Phenotype and Inheritance in Patients With C9ORF72 Hexanucleotide Repeat Expansion: Results From a Large French Cohort , 2020, Frontiers in Neuroscience.

[8]  L. Petrucelli,et al.  Elevated methylation levels, reduced expression levels, and frequent contractions in a clinical cohort of C9orf72 expansion carriers , 2020, Molecular Neurodegeneration.

[9]  A. Chiò,et al.  ALS phenotype is influenced by age, sex, and genetics , 2020, Neurology.

[10]  S. Ajroud‐Driss,et al.  Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort , 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[11]  C. Gellera,et al.  The first case of the TARDBP p.G294V mutation in a homozygous state: is a single pathogenic allele sufficient to cause ALS? , 2019, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[12]  S. Abdelhak,et al.  Consanguinity and Inbreeding in Health and Disease in North African Populations. , 2019, Annual review of genomics and human genetics.

[13]  G. Patrinos,et al.  The role of C9orf72 in neurodegenerative disorders: a systematic review, an updated meta-analysis, and the creation of an online database , 2019, Neurobiology of Aging.

[14]  S. Lehéricy,et al.  Relations between C9orf72 expansion size in blood, age at onset, age at collection and transmission across generations in patients and presymptomatic carriers , 2019, Neurobiology of Aging.

[15]  P. Preux,et al.  Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study , 2018, Journal of Neurology, Neurosurgery, and Psychiatry.

[16]  Takeo Kato,et al.  TARDBP p.G376D mutation, found in rapid progressive familial ALS, induces mislocalization of TDP-43 , 2018, eNeurologicalSci.

[17]  Alan J. Thomas,et al.  TDP‐43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing , 2017, Brain pathology.

[18]  D. Dormann,et al.  TDP‐43 and FUS en route from the nucleus to the cytoplasm , 2017, FEBS letters.

[19]  L. Pagani,et al.  Ancient and recent admixture layers in Sicily and Southern Italy trace multiple migration routes along the Mediterranean , 2017, Scientific Reports.

[20]  Mark R. Wilson,et al.  Flow cytometric measurement of the cellular propagation of TDP-43 aggregation , 2017, Prion.

[21]  Zhi-rui Zhou,et al.  Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2017, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  A. Al-Chalabi,et al.  Amyotrophic lateral sclerosis: moving towards a new classification system , 2016, The Lancet Neurology.

[23]  Hong-Fu Li,et al.  Genotype-phenotype correlations of amyotrophic lateral sclerosis , 2016, Translational Neurodegeneration.

[24]  M. Mesulam,et al.  Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene , 2014, Molecular Neurodegeneration.

[25]  Y. Chern,et al.  The Influence of Pathological Mutations and Proline Substitutions in TDP-43 Glycine-Rich Peptides on Its Amyloid Properties and Cellular Toxicity , 2014, PloS one.

[26]  P. Vourc'h,et al.  Benign lower limb amyotrophy due to TARDBP mutation or post-polio syndrome? , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[27]  M. Swash,et al.  Controversies and priorities in amyotrophic lateral sclerosis , 2013, The Lancet Neurology.

[28]  Leonard H van den Berg,et al.  Evidence for an oligogenic basis of amyotrophic lateral sclerosis. , 2012, Human molecular genetics.

[29]  O. Hardiman,et al.  Proposed criteria for familial amyotrophic lateral sclerosis , 2011, Amyotrophic Lateral Sclerosis.

[30]  G. Tedeschi,et al.  TARDBP gene mutations in south Italian patients with amyotrophic lateral sclerosis , 2010, Journal of Neurology Neurosurgery & Psychiatry.

[31]  N. Bresolin,et al.  TARDBP (TDP‐43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations , 2009, European journal of neurology.

[32]  B. Castellotti,et al.  High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis , 2009, Human mutation.

[33]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[34]  Robert H. Brown,et al.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.

[35]  Christopher R Watts,et al.  BMC Ear, Nose and Throat Disorders BioMed Central BMC 1 2001, Ear, Nose and Throat Disorders , 2001 .

[36]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[37]  P. Andersen,et al.  Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase , 1995, Nature Genetics.

[38]  M. Hamida,et al.  Hereditary motor system diseases (chronic juvenile amyotrophic lateral sclerosis). Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy. , 1990, Brain : a journal of neurology.

[39]  M. Ben Hamida,et al.  [Charcot's disease and juvenile amyotrophic lateral sclerosis]. , 1984, Revue neurologique.